India, Jan. 24 -- With cancer incidence rising globally, several Indian pharmaceutical companies are strengthening their presence in oncology. Stocks such as Sun Pharma, Dr Reddy's, Cipla, Glenmark, and Zydus Life Sciences are playing a crucial role by offering affordable cancer drugs, biosimilars, and innovative immunotherapy solutions, positioning India as a major hub for global cancer treatment.

Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs). The company and its subsidiaries have various manufacturing facilities spread across the world, with trading and oth...